Literature DB >> 8826000

Hematological effects of radiant heat-induced whole body hyperthermia on dogs.

J P Woods1, C L Schmitt-Tiggelaar, F d'Oleire, R C Rosenthal, H I Robins.   

Abstract

The effects on hematological parameters of radiant heat-induced whole body hyperthermia (WBH) at 40.5 degrees C and 41.8 degrees C were determined in 6 normal dogs. Complete blood counts determined prior to WBH, immediately post WBH plateau, and at 1, 2, 7, and 14 days posttreatment did not change significantly following WBH at 40.5 degrees C or 41.8 degrees C. Similarly, no significant changes were detected in platelet counts measured following 40.5 degrees C WBH. In contrast, platelet counts 11 days following 41.8 degrees C WBH increased significantly (P < 0.05) consistent with the hypothesis of induction of putative WBH-induced platelet stimulating factors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8826000      PMCID: PMC1263806     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  18 in total

1.  Cytokine induction in humans by 41.8 degrees C whole-body hyperthermia.

Authors:  F D'Oleire; C L Schmitt; H I Robins; J D Cohen; D Spriggs
Journal:  J Natl Cancer Inst       Date:  1993-05-19       Impact factor: 13.506

Review 2.  Whole-body hyperthermia. Rationale and potential use for cancer treatment.

Authors:  R L Page; D E Thrall; M W Dewhirst; R E Meyer
Journal:  J Vet Intern Med       Date:  1987 Jul-Sep       Impact factor: 3.333

3.  Physiological studies of whole-body hyperthermia of dogs.

Authors:  D W Macy; C A Macy; R J Scott; E L Gillette; J F Speer
Journal:  Cancer Res       Date:  1985-06       Impact factor: 12.701

4.  A new technological approach to radiant heat whole body hyperthermia.

Authors:  H I Robins; J P Woods; C L Schmitt; J D Cohen
Journal:  Cancer Lett       Date:  1994-05-16       Impact factor: 8.679

5.  Adjunctive therapy (whole body hyperthermia versus lonidamine) to total body irradiation for the treatment of favorable B-cell neoplasms: a report of two pilot clinical trials and laboratory investigations.

Authors:  H I Robins; W L Longo; R A Steeves; J D Cohen; C L Schmitt; A J Neville; S O'Keefe; R Lagoni; C Riggs
Journal:  Int J Radiat Oncol Biol Phys       Date:  1990-04       Impact factor: 7.038

6.  Phase I clinical trial of carboplatin and 41.8 degrees C whole-body hyperthermia in cancer patients.

Authors:  H I Robins; J D Cohen; C L Schmitt; K D Tutsch; C Feierabend; R Z Arzoomanian; D Alberti; F d'Oleire; W Longo; C Heiss
Journal:  J Clin Oncol       Date:  1993-09       Impact factor: 44.544

7.  Differential sensitivity of AKR murine leukemia and normal bone marrow cells to hyperthermia.

Authors:  H I Robins; R A Steeves; A W Clark; P A Martin; K Miller; W H Dennis
Journal:  Cancer Res       Date:  1983-10       Impact factor: 12.701

8.  The effects of treatment with interleukin-1 alpha on platelet recovery after high-dose carboplatin.

Authors:  J W Smith; D L Longo; W G Alvord; J E Janik; W H Sharfman; B L Gause; B D Curti; S P Creekmore; J T Holmlund; R G Fenton
Journal:  N Engl J Med       Date:  1993-03-18       Impact factor: 91.245

9.  Synergy of interleukin 1 and granulocyte colony-stimulating factor: in vivo stimulation of stem-cell recovery and hematopoietic regeneration following 5-fluorouracil treatment of mice.

Authors:  M A Moore; D J Warren
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

10.  Cardiovascular and metabolic response of tumour-bearing dogs to whole body hyperthermia.

Authors:  R L Page; R E Meyer; D E Thrall; M W Dewhirst
Journal:  Int J Hyperthermia       Date:  1987 Nov-Dec       Impact factor: 3.914

View more
  1 in total

1.  No effects of acclimation to heat on immune and hormonal responses to passive heating in healthy volunteers.

Authors:  Dominika Kanikowska; Maki Sato; Junichi Sugenoya; Satoshi Iwase; Yuuki Shimizu; Naoki Nishimura; Yoko Inukai
Journal:  Int J Biometeorol       Date:  2011-01-11       Impact factor: 3.787

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.